|
1
|
Malfertheiner P, Megraud F, O'Morain CA,
Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton
J, Graham DY, et al: European Helicobacter and Microbiota
Study Group and Consensus panel: Management of Helicobacter
pylori infection - the Maastricht V/Florence Consensus Report.
Gut. 66:6–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cheng H, Hu F, Zhang L, Yang G, Ma J, Hu
J, Wang W, Gao W and Dong X: Prevalence of Helicobacter
pylori infection and identification of risk factors in rural
and urban Beijing, China. Helicobacter. 14:128–133. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Klein PD, Graham DY, Gaillour A, Opekun AR
and Smith EO: Gastrointestinal Physiology Working Group. Water
source as risk factor for Helicobacter pylori infection in
Peruvian children. Lancet. 337:1503–1506. 1991.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hopkins RJ, Vial PA, Ferreccio C, Ovalle
J, Prado P, Sotomayor V, Russell RG, Wasserman SS and Morris JG Jr:
Seroprevalence of Helicobacter pylori in Chile: Vegetables
may serve as one route of transmission. J Infect Dis. 168:222–226.
1993.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Goodman KJ, Correa P, Tenganá Aux HJ,
Ramírez H, DeLany JP, Guerrero Pepinosa O, López Quiñones M and
Collazos Parra T: Helicobacter pylori infection in the
Colombian Andes: A population-based study of transmission pathways.
Am J Epidemiol. 144:290–299. 1996.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Brown LM: Helicobacter pylori:
Epidemiology and routes of transmission. Epidemiol Rev. 22:283–297.
2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hu Y, Wan JH, Li XY, Zhu Y, Graham DY and
Lu NH: Systematic review with meta-analysis: The global recurrence
rate of Helicobacter pylori. Aliment Pharmacol Ther.
46:773–779. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Venneman K, Huybrechts I, Gunter MJ,
Vandendaele L, Herrero R and Van Herck K: The epidemiology of
Helicobacter pylori infection in Europe and the impact of
lifestyle on its natural evolution toward stomach cancer after
infection: A systematic review. Helicobacter.
23(e12483)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hooi JKY, Lai WY, Ng WK, Suen MMY,
Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu
JC, et al: Global prevalence of Helicobacter pylori
infection: Systematic review and meta-analysis. Gastroenterology.
153:420–429. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Roberts SE, Morrison-Rees S, Samuel DG,
Thorne K, Akbari A and Williams JG: The prevalence of
Helicobacter pylori and the incidence of gastric cancer
across Europe (Review). Aliment Pharmacol Ther. 43:334–345.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Andreica V, Dumitraşcu D, Sască N, Toganel
E, Suciu A, Drăghici A, Pascu O, Sască C, Suciu M, Andreica M, et
al: Helicobacter-like organisms in gastroduodenal diseases.
Gastroenterol Clin Biol. 14:437–441. 1990.PubMed/NCBI
|
|
12
|
Chen TS, Li FY, Chang FY and Lee SD:
Immunoglobulin G antibody against Helicobacter pylori:
Clinical implications of levels found in serum. Clin Diagn Lab
Immunol. 9:1044–1048. 2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lahner E, Bordi C, Di Giulio E, Caruana P,
D'Ambra G, Milione M, Grossi C, Delle Fave G and Annibale B: Role
of Helicobacter pylori serology in atrophic body gastritis
after eradication treatment. Aliment Pharmacol Ther. 16:507–514.
2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pérez-Pérez GI, Cutler AF and Blaser MJ:
Value of serology as a noninvasive method for evaluating the
efficacy of treatment of Helicobacter pylori infection. Clin
Infect Dis. 25:1038–1043. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Cutler A, Schubert A and Schubert T: Role
of Helicobacter pylori serology in evaluating treatment
success. Dig Dis Sci. 38:2262–2266. 1993.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Serban R, Grigorescu-Sido P, Gheban D and
Kiss E: Helicobacter pylori gastritis in children:
Endoscopical and histological aspects. Rom J Gastroenterol.
11:297–301. 2002.PubMed/NCBI
|
|
17
|
Miller LC, Kelly N, Tannemaat M and Grand
RJ: Serologic prevalence of antibodies to Helicobacter
pylori in internationally adopted children. Helicobacter.
8:173–178. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Domșa T, Gheban D, Rădulescu A and Borzan
C: Preliminary research on Helicobacter pylori infection in
hospitalized children from northwestern Romania. J Mol Biol.
1:119–120. 2018.
|
|
19
|
Sporea I, Popescu A, van Blankenstein M,
Sirli R, Focşea M and Dănilă M: The prevalence of Helicobacter
pylori infection in western Romania. Rom J Gastroenterol.
12:15–18. 2003.PubMed/NCBI
|
|
20
|
Prunduș C, Ciobanu L, Bolboacă S, Tanțău
M, Matei D, Cruciat C, Pojoga C and Andreica V: The evolution over
time of the prevalence of Helicobacter pylori infection
among patients with dyspeptic syndrome - the experience of a
tertiary center in Romania. Med Connect. 13:23–27. 2018.
|
|
21
|
Andreica V and Andreica M: Helicobacter
pylori infection in stomach and duodenal diseases. Hipocrate,
Sibiu, pp10-25, 1994.
|
|
22
|
Ciobanu L, Prundus R and Diaconu B:
Epidemiological trends of Helicobacter pylori prevalence in
central-western part of Romania. J Gastrointest Liv Dis.
18(17)2009.
|
|
23
|
Ciobanu L, Taulescu M and Dumitrascu DL:
Helicobacter pylori in Romania: Epidemiology, diagnosis and
treatment. In: Helicobacter pylori: A Worldwide Perspective,
2014. Buzas GM (ed). Vol 1. Bentham Science Publishers, Oak Park,
IL, pp183-201, 2014.
|
|
24
|
Olar L, Mitrut P, Florou C, Mălăescu GD,
Predescu OI, Rogozea LM, Mogoantă L, Ionovici N and Pirici I:
Evaluation of Helicobacter pylori infection in patients with
eso-gastro-duodenal pathology. Rom J Morphol Embryol. 58:809–815.
2017.PubMed/NCBI
|
|
25
|
Valean S, Chira R and Dumitrascu D:
Epidemiological trends in digestive cancers in Romania, 1955-2012,
compared to alcohol consumption Correlation or coincidence? Clujul
Med. 91:376–386. 2018.PubMed/NCBI View Article : Google Scholar
|
